Company: AIP
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001667011-25-000029
Chunk: 1

Company: Arteris, Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
 30, 2025 and December 31, 2024; 42,592,418 and 40,724,936 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively42 40 Additional paid-in capital146,350 135,522 Accumulated other comprehensive income215 135 Accumulated deficit(154,136)(136,885)Total stockholders' deficit(7,529)(1,188)TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT$106,880 $106,135 

See accompanying notes to unaudited condensed consolidated financial statements.

3

Table of Contents

Arteris, Inc.

Condensed Consolidated Statements of Operations

(In thousands, except share and per share data)

(Unaudited)

Three Months EndedJune 30,Six Months Ended June 30,2025202420252024RevenueLicensing, support and maintenance$15,088 $13,553 $30,423 $25,292 Variable royalties and other1,414 1,022 2,611 2,230 Total revenue16,502 14,575 33,034 27,522 Cost of revenue1,742 1,458 3,268 2,926 Gross profit14,760 13,117 29,766 24,596 Operating expenses:Research and development12,171 10,717 24,033 21,552 Sales and marketing6,335 5,013 12,864 10,469 General and administrative4,502 4,828 8,825 9,150 Total operating expenses23,008 20,558 45,722 41,171 Loss from operations(8,248)(7,441)(15,956)(16,575)Interest expense(42)(68)(90)(144)Other income (expense), net786 865 1,504 1,801 Loss before income taxes and loss from equity method investment (7,504)(6,644)(14,542)(14,918)Loss from equity method investment, net of tax780 725 1,595 1,484 Provision for income taxes846 975 1,114 1,345 Net loss$(9,130)$(8,344)$(17,251)$(17,747)